← 返回

Autotaxin 通过抑制 CD8(+) T 细胞的趋化性和肿瘤浸润来阻碍抗肿瘤免疫

英文原题:Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8(+) T cells.

查看英文原题

Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8(+) T cells.

PubMed 2021/11/16(内容时间) Cell Rep Q1 · IF 7.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

Autotaxin(ATX;ENPP2)产生溶血磷脂酸(LPA),通过同源G蛋白偶联受体LPAR1-6调控多种生物学功能。ATX/LPA通过LPAR1促进肿瘤细胞迁移和转移,并通过LPAR2促进T细胞运动,但其在肿瘤免疫微环境中的作用仍不清楚。在此,我们表明黑色素瘤细胞分泌的ATX对TIL(肿瘤浸润淋巴细胞)(TILs)和循环CD8+ T细胞具有趋避作用,ATX作为产生LPA的伴侣蛋白发挥作用。在机制上,T细胞排斥主要涉及Gα12/13偶联的LPAR6。对荷瘤小鼠进行抗癌疫苗接种后,ATX不影响系统性T细胞应答的诱导,但重要的是,它抑制细胞毒性CD8+ T细胞向肿瘤的浸润,从而损害肿瘤消退。此外,来自黑色素瘤肿瘤的单细胞数据与瘤内ATX作为T细胞排斥剂的作用一致。这些发现突出了促转移ATX-LPAR轴在抑制CD8+ T细胞浸润以阻碍抗肿瘤免疫中的意外作用,提示了新的治疗机会。

展开英文摘要原文

Autotaxin (ATX; ENPP2) produces lysophosphatidic acid (LPA) that regulates multiple biological functions via cognate G protein-coupled receptors LPAR1-6. ATX/LPA promotes tumor cell migration and metastasis via LPAR1 and T cell motility via LPAR2, yet its actions in the tumor immune microenvironment remain unclear.

Here, we show that ATX secreted by melanoma cells is chemorepulsive for tumor-infiltrating lymphocytes (TILs) and circulating CD8 + T cells ex vivo, with ATX functioning as an LPA-producing chaperone.

Mechanistically, T cell repulsion predominantly involves Gα 12/13 -coupled LPAR6. Upon anti-cancer vaccination of tumor-bearing mice, ATX does not affect the induction of systemic T cell responses but, importantly, suppresses tumor infiltration of cytotoxic CD8 + T cells and thereby impairs tumor regression.

Moreover, single-cell data from melanoma tumors are consistent with intratumoral ATX acting as a T cell repellent.

These findings highlight an unexpected role for the pro-metastatic ATX-LPAR axis in suppressing CD8 + T cell infiltration to impede anti-tumor immunity, suggesting new therapeutic opportunities.

论文信息

作者
Matas-Rico E、Frijlink E、van der Haar Àvila I、Menegakis A、van Zon M、Morris AJ、Koster J、Salgado-Polo F
第一作者单位
Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: ematas@uma.es.Netherlands
通讯作者单位
Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: w.moolenaar@nki.nl.Netherlands
文献类型
美国 NIH 资助研究 · 非美国政府资助研究
期刊
Cell reports2021 Nov 16
原文标识
PubMed 34788605 · DOI 10.1016/j.celrep.2021.110013